A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia

Cited by (692)

Items 401–500 of 692

1. From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in Hematopoiesis
   Roger Mulet‐Lazaro, Ruud Delwel · 2023 · HemaSphere
2. Inside the Battle Against Acute Myeloid Leukemia: Biology, Breakthroughs, and Hope
   Jiayang Bao, Oliver Freund, Logan Sund, Wei Du · 2026 · Cells
3. Looking for Broken TAD Boundaries and Changes on DNA Interactions: Clinical Guide to 3D Chromatin Change Analysis in Complex Chromosomal Rearrangements and Chromothripsis
   Kévin Yauy, Vincent Gâtinois, Thomas Guignard, Satish Sati, Jacques Puechberty, Jean Baptiste Gaillard, Anouck Schneider, Franck Pellestor · 2018 · Methods in molecular biology
4. RETRACTED: Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies
   Mariam Markouli, Dimitrios Strepkos, Christina Piperi · 2022 · International Journal of Molecular Sciences · Retracted
5. Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijacking
   Dieter Weichenhan, Anna Riedel, Charlotte Meinen, Alisa Basic, Réka Tóth, Marion Bähr, Pavlo Lutsik, Joschka Hey, Etienne Sollier, Umut H. Toprak et al. · 2023 · Leukemia
6. Acinic Cell Carcinoma in the 21st Century: A Population-Based Study from the SEER Database and Review of Recent Molecular Genetic Advances
   Jaffar Khan, Asad Ullah, Mya Goodbee, Kue Tylor Lee, Abdul Qahar Khan Yasinzai, James S. Lewis, Hector A. Mesa · 2023 · Cancers
7. A novel GATA2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins
   Robert R. West, Thomas R. Bauer, Laura M. Tuschong, Lisa J. Embree, Katherine R. Calvo, Desiree Tillo, Joie Davis, Steven M. Holland, Dennis D. Hickstein · 2023 · Blood Advances
8. Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations: a case report
   Sebastián Podlipnik, Francesca Guijarro, Andrea Combalía, Jordi To‐Figueras, Célia Bádenas, Dolors Costa, Marı́a Rozman, Jorge Sierra, Paula Aguilera, Anna Gayà · 2017 · British Journal of Dermatology
9. H2AFY is a novel fusion partner of MECOM in acute myeloid leukemia
   Qiaoyan Han, Jiao Lu, Jianjiang Wang, Jinsong Ye, Xin Jiang, Haoyue Chen, Chunhua Liu, Lu Chen, Tong Lin, Suning Chen et al. · 2018 · Cancer Genetics
10. BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias
    Aline Massé, Louise Roulin, Justine Pasanisi, Justine Penneroux, Stéphanie Gachet, Marc Delord, Ashfaq Ali, Antonio Alberdi, Jeannig Berrou, Marie Passet et al. · 2019 · Leukemia Research
11. Super-Enhancers Dysregulations in Hematological Malignancies
    Yannis Belloucif, Camille Lobry · 2022 · Cells
12. Enhancers and their dynamics during hematopoietic differentiation and emerging strategies for therapeutic action
    Alba Cico, Charlotte Andrieu‐Soler, Éric Soler · 2016 · FEBS Letters
13. Emerging molecular predictive and prognostic factors in acute myeloid leukemia
    Shannon R. McCurdy, Mark J. Levis · 2017 · Leukemia & lymphoma/Leukemia and lymphoma
14. Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
    Oskar Marín-Béjar, Damià Romero–Moya, Javier Rodríguez‐Ubreva, Maximiliano Distefano, Francesca Lessi, Paolo Aretini, Alessandro Liquori, Julio Castaño, Emilia J. Kozyra, Lili Kotmayer et al. · 2023 · Haematologica
15. Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15
    Michelle Shu Wen Ng, Lonneke Verboon, Hasan Issa, Raj Bhayadia, Marit Willemijn Vermunt, Robert Winkler, Leah Schüler, Oriol Alejo-Valle, K Schuschel, Enikő Regényi et al. · 2023 · iScience
16. PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells
    Casey D. S. Katerndahl, Olivia R. S. Rogers, Ryan B. Day, Ziheng Xu, Nichole Helton, Sai Mukund Ramakrishnan, Christopher A. Miller, Timothy James Ley · 2024 · Proceedings of the National Academy of Sciences
17. Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia
    Sunniyat Rahman, Gianna Bloye, Nadine Farah, Jonas Demeulemeester, Joana R. Costa, David O’Connor, Rachael Pocock, Tanya Rapoz-D’Silva, Adam Turňa, Lingyi Wang et al. · 2024 · Blood
18. MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia
    Dorien Pastoors, Marije Havermans, Roger Mulet‐Lazaro, Leonie Smeenk, Sophie Ottema, Claudia A. J. Erpelinck-Verschueren, Stanley van Herk, Maikel Anthonissen, Tim Grob, Shruthi Subramanian et al. · 2025 · Blood
19. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency
    Avigail Rein, Ifat Geron, Eitan Kugler, Hila Fishman, Eyal Gottlieb, Ifat Abramovich, Amir Giladi, Ido Amit, Roger Mulet‐Lazaro, Ruud Delwel et al. · 2022 · Haematologica
20. Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites
    Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, Luigi Emilio Xodo, Claudio Brancolini · 2023 · International review of cytology
21. dbInDel: a database of enhancer-associated insertion and deletion variants by analysis of H3K27ac ChIP-Seq
    Mo-Li Huang, Yun-Peng Wang, Manqiu Yang, Jun Yan, Henry Yang, Wen-Zhuo Zhuang, Ying Xu, H. Koeffler, D. Lin, Xi Chen · 2019 · Bioinform.
22. Enhancers and MYC interplay in hematopoiesis
    Leonidas Benetatos, Agapi Benetatou, George Vartholomatos · 2020 · Journal of Molecular Medicine
23. GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1
    Preeti Singh, Maninder Heer, Anastasia Resteu, Aneta Mikulášová, Mojgan Reza, Laëtitia Largeaud, Stéphanie Dufrechou, Naïs Prade, Rachel Emma Dickinson, Jacinta C. Bustamante et al. · 2021 · Blood Advances
24. HDAC4 super-enhancer drives CEBPB-mediated TWIST2 transcription to promote chemoresistance in LUAD
    Min Jiang, Kai Zhang, Guohao Wei, Feng Qi, Danlei Yu, MA Jingjing, Xiaofei Zhang, 陈龙邦, Yuhao Xie, Zhengyuan Yu et al. · 2025 · Cancer Letters
25. Rewiring cancer epigenome: lncRNA as modulator of chromatin architecture and neoplastic transformation
    Santosh Kumar, Subhadip Kundu, Surender Kumar Sharawat, Ashok Kumar Sharma · 2025 · Mammalian Genome
26. C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation
    Anna E. Marneth, Koen H.M. Prange, Adil S. A. Al Hinai, Saskia M. Bergevoet, Niccoló Tesi, Eva M. Janssen‐Megens, B Kim, Nilofar Sharifi, Marie‐Laure Yaspo, Jorren Kuster et al. · 2017 · Leukemia
27. Hi-C analysis of genomic contacts revealed karyotype abnormalities in chicken HD3 cell line
    Antonina Maslova, V. Plotnikov, Miroslav Nuriddinov, Maria M. Gridina, Veniamin Fishman, Alla Krasikova · 2023 · BMC Genomics
28. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH)
    Nathalie Auger, Nathalie Douet‐Guilbert, Julie Quessada, Olivier Theisen, Mårina Lafage‐Pochitaloff, Marie‐Bérengère Troadec · 2023 · Current Research in Translational Medicine
29. 3C methods in cancer research: recent advances and future prospects
    Insoo Yoon, Uijin Kim, Kyung Oh Jung, Yousuk Song, Taesoo Park, Dong-Sung Lee · 2024 · Experimental & Molecular Medicine
30. SETBP1 is dispensable for normal and malignant hematopoiesis
    Atsushi Tanaka, Koutarou Nishimura, Wataru Saika, Ayana Kon, Yui Koike, Hiromi Tatsumi, June Takeda, Masaki Nomura, Weijia Zang, Manabu Nakayama et al. · 2023 · Leukemia
31. High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma
    Paul Jank, Jonas Leichsenring, Svenja Kolb, Inga Hoffmann, Philip Bischoff, Catarina Alisa Kunze, Mihnea Paul Dragomir, Moritz Gleitsmann, Moritz Jesinghaus, Wolfgang Schmitt et al. · 2023 · Journal of Ovarian Research
32. 3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms
    Zhihong Hu, Leonard Jeffrey Medeiros, Wei Wang, Zi Chen, Guilin Tang, Parsa Hodjat, Su Yang, Lianghua Fang, Yan Li, Srđan Verstovšek et al. · 2017 · Modern Pathology
33. Promoter–Enhancer Looping and Regulatory Neighborhoods
    Charbel Souaid, Sébastien Bloyer, Daan Noordermeer · 2017 · Elsevier eBooks
34. Two effects of GATA2 enhancer repositioning by 3q chromosomal rearrangements
    Mikiko Suzuki, Saori Katayama, Masayuki P. Yamamoto · 2019 · IUBMB Life
35. Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities
    David Andrew Sallman, John Barnard, Najla H. Al Ali, Guillermo Garcia‐Manero, Mikkael Aaron Sekeres, Amy Elizabeth Dezern, David P. Steensma, Gail J. Roboz, Elias Joseph Jabbour, Jaroslaw Pawel Maciejewski et al. · 2020 · Clinical Lymphoma Myeloma & Leukemia
36. EVI1 protein interaction dynamics: Targetable for therapeutic intervention?
    Roberto Paredes, Nora Julia Doleschall, Kathleen Connors, Bethany Geary, Stefan Meyer · 2021 · Experimental Hematology
37. dbSUPER: a database of super-enhancers in mouse and human genome
    Aziz Khan, Xuegong Zhang · 2015 · bioRxiv (Cold Spring Harbor Laboratory)
38. Genetic and Epigenetic Dysregulation of Transcriptional Enhancers in Cancer
    Giovanni A. Botten, Jian Xu · 2024 · Annual Review of Cancer Biology
39. Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
    Etienne Sollier, Anna Riedel, Umut H. Toprak, Justyna A. Wierzbińska, Dieter Weichenhan, Jan Philipp Schmid, Mariam Hakobyan, Aurore Touzart, Ekaterina Jahn, Binje Vick et al. · 2025 · Blood Cancer Discovery
40. Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: a case report
    Margaret O. Lewen, Renee C. Gresh, Maria Queenan, Michele E. Paessler, Vinodh Pillai, Elizabeth Olson Hexner, Dale M. Frank, Adam Bagg, Richard Aplenc, Emi Caywood et al. · 2016 · Biomarker Research
41. Scarcity of Recurrent Regulatory Driver Mutations in Colorectal Cancer Revealed by Targeted Deep Sequencing
    Rebecca C. Poulos, D. S. Perera, Deborah Packham, Anushi Shah, Caroline Janitz, John E. Pimanda, Nicholas John Hawkins, Robyn Lynne Ward, Luke B. Hesson, Jason W.H. Wong · 2019 · JNCI Cancer Spectrum
42. EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells
    Alexander M. Grandits, Sophie Bromberger, Gerwin Heller, Barbara Andrea Reinoehl, Erwin Tomasich, Klaudia Schossleitner, Anna Sophie Berghoff, Thorsten Fuereder, Rotraud Wieser · 2022 · International Journal of Molecular Sciences
43. Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy
    Jiarna R. Zerella, Claire C. Homan, Peer Arts, Anna L Brown, Hamish S. Scott, Christopher Norman Hahn · 2023 · Frontiers in Oncology
44. Épigénétique, principes et exemples d’applications
    Caroline Dion, Camille Laberthonnìère, Frédérique Magdinier · 2023 · La Revue de Médecine Interne
45. Quantitative Trait Loci Identify Functional Noncoding Variation in Cancer
    Holger Heyn · 2016 · PLoS Genetics
46. VCF2CNA: A tool for efficiently detecting copy-number alterations in VCF genotype data and tumor purity
    Daniel K. Putnam, Xiaotu Ma, Stephen V. Rice, Yu Liu, Scott Newman, Jinghui Zhang, Xiang 'Anthony' Chen · 2019 · Scientific Reports
47. Insights from Patients with Dendritic Cell Immunodeficiency
    Venetia Bigley, Matthew P. Collin · 2020 · Molecular Immunology
48. Establishment of a High‐risk MDS/AML Cell Line YCU‐AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7
    Hiroyoshi Kunimoto, Yumi Fukuchi, Koichi Murakami, Junji Ikeda, Hiroshi Teranaka, Ikuma Kato, Takuya Miyazaki, Makiko Enaka, Takayuki Mitsuhashi, Etsuko Yamazaki et al. · 2020 · HemaSphere
49. NKL Homeobox Gene VENTX Is Part of a Regulatory Network in Human Conventional Dendritic Cells
    Stefan Nagel, Claudia Pommerenke, Corinna Meyer, Hans Günter Drexler · 2021 · International Journal of Molecular Sciences
50. Two unrelated distal genes activated by a shared enhancer benefit from localizing inside the same small topological domain
    Yike Huang, Marjon J.A.M. Verstegen, Sjoerd J. D. Tjalsma, Peter H.L. Krijger, Kavvya Gupta, Minhee Park, Alistair Nicol Boettiger, Wouter L. de Laat · 2025 · Genes & Development
51. Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML
    Matteo Marchesini, Andrea Gherli, Elisa Simoncini, Lucas Moron Dalla Tor, Anna Montanaro, Natthakan Thongon, Federica Vento, Chiara Liverani, Elisa Cerretani, Anna D’Antuono et al. · 2024 · Nature Communications
52. Computational Approaches for Understanding Sequence Variation Effects on the 3D Genome Architecture
    Pavel Avdeyev, Jian Zhou · 2022 · Annual Review of Biomedical Data Science
53. Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)
    Audrey Bidet, Julie Quessada, Wendy Cuccuini, Matthieu Décamp, Mårina Lafage‐Pochitaloff, Isabelle Luquet, Christine Lefebvre, Giulia Tueur · 2023 · Current Research in Translational Medicine
54. Novel genetically glycoengineered human dendritic cell model reveals regulatory roles of α2,6-linked sialic acids in DC activation of CD4+ T cells and response to TNFα
    Weihua Tian, Anne Louise Blomberg, Kaylin Steinberg, Betina Lyngfeldt Henriksen, Josefine Søborg Jørgensen, Kerstin Skovgaard, Sarah Line Skovbakke, Steffen Goletz · 2024 · Glycobiology
55. Genomic Dark Matter Sheds Light on EVI1-Driven Leukemia
    Richard P. Koche, Scott A. Armstrong · 2014 · Cancer Cell
56. Genes break barrier between MDS and AML
    Claudia Haferlach · 2015 · Blood
57. Reprint of: Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
    Paresh Vyas, Frederick R. Appelbaum, Charles Craddock · 2015 · Transplantation and Cellular Therapy
58. Breast cancer risk-associated variants at 6q25.1 influence risk of hepatocellular carcinoma in a Chinese population
    Jiaoyuan Li, Ying Wang, Ying Zhu, Yajie Gong, Yang Yang, Jianbo Tian, Yi Zhang, Danyi Zou, Xiating Peng, Juntao Ke et al. · 2017 · Carcinogenesis
59. No Need to Stick Together to Be Connected: Multiple Types of Enhancers’ Networking
    Emanuele Vitale, Mila Gugnoni, Alessia Ciarrocchi · 2021 · Cancers
60. Gata2 −77 enhancer regulates adult hematopoietic stem cell survival
    Xiaona You, Yuan‐I Chang, Guangyao Kong, Erik A. Ranheim, Yun Zhou, Kirby D. Johnson, Charu Mehta, Emery H. Bresnick, Jing Zhang · 2020 · Leukemia
61. EVI1-Positive Leukemias and Myelodysplastic Syndromes: Theoretical and Clinical Aspects (Literature Review)
    Mamaev Nn, Alena Igorevna Shakirova, Еlena V. Morozova, Tatiana Gindina · 2021 · Clinical oncohematology
62. Gene expression at a single-molecule level: implications for myelodysplastic syndromes and acute myeloid leukemia
    Justin C. Wheat, Ulrich G. Steidl · 2021 · Blood
63. In vivo temporal resolution of acute promyelocytic leukemia progression reveals a role of Klf4 in suppressing early leukemic transformation
    Glòria Mas Martín, Fabio Santoro, Enrique Blanco, Gianni Paolo Gamarra Figueroa, François Le Dily, Gianmaria Frigè, Enrique Vidal, Francesca Mugianesi, Cecilia Ballaré, Arantxa Gutiérrez et al. · 2022 · Genes & Development
64. Current progress and future perspective of super-enhancers: a viable and effective bridge between the transcriptional apparatus and disease
    Ran Wang, Aiying Li, Zongran Pang · 2025 · Frontiers in Genetics
65. Super-enhancer DNA methylation in cancer: the mechanism of action and therapeutic directions
    Yue Bi, Kang Zou, Ke Wang · 2025 · Frontiers in Oncology
66. Super enhancers as key drivers of gene regulatory networks in normal and malignant hematopoiesis
    Ying Cheng, Guangxin Pei, Hengchao Zhang, Yan Hou, Lei Sun, H. Xu, Yuning Lv, Xiuyun Wu · 2025 · Frontiers in Cell and Developmental Biology
67. Somatic structural variants drive distinct modes of oncogenesis in melanoma
    Jake R. Conway, Riaz Gillani, Jett P. Crowdis, Brendan Michael Reardon, Jihye Park, Seunghun Han, Breanna M. Titchen, Mouadh Benamar, Rizwan Haq, Eliezer M. Van Allen · 2024 · Journal of Clinical Investigation
68. MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemia
    Wei‐Ying Jen, Guilin Tang, Eitan Kugler, Jennifer Croden, Koji Sasaki, Alexandre Bazinet, Álex Bataller, Guillermo Montalban Bravo, Gautam M. Borthakur, Gökçe Törüner et al. · 2025 · British Journal of Haematology
69. MECOM-Rearranged Acute Myeloid Leukemia: Pathobiology and Management Strategies
    Utsav Joshi, Rory Michael Shallis · 2025 · Hematology Reports
70. Hi-C for genome-wide detection of enhancer-hijacking rearrangements in routine lymphoid cancer biopsies
    Jamin Wu, Alec Chu, Jang Cho, Misha Movahed-Ezazi, Kristyn Galbraith, Camila S. Fang, Yiying Yang, Chanel Schroff, Kristin L Sikkink, Michelle Perez-Arreola et al. · 2026 · Cell Genomics
71. Haploinsufficient Transcription Factors in Myeloid Neoplasms
    Tanner C. Martinez, Megan E. McNerney · 2023 · Annual Review of Pathology Mechanisms of Disease
72. Influence of genetic co‐mutation on chemotherapeutic outcome in NPM1‐mutated and FLT3‐ITD wild‐type AML patients
    Qian Vicky Wu, Yujiao Zhang, Baoyi Yuan, Yun Huang, Ling Jiang, Fang Liu, Ping Yan, Jiaying Cheng, Zhiquan Long, Xuejie Jiang · 2024 · Cancer Medicine
73. Mechanisms of enhancer‐driven oncogene activation
    Joyce Vriend, Ruud Delwel, Dorien Pastoors · 2025 · International Journal of Cancer
74. Reactivation of developmentally silenced globin genes through forced linear recruitment of remote enhancers
    Anna-Karina Felder, Sjoerd J. D. Tjalsma, Han J. M. P. Verhagen, Rezin Majied, Marjon J.A.M. Verstegen, Thijs C. J. Verheul, Jeffrey van Haren, Rebecca Mohnani, Richard Gremmen, Peter H.L. Krijger et al. · 2025 · Blood
75. Dynamic chromatin organization: Role in development and disease
    Tatyana Kuznetsova, Hendrik G. Stunnenberg · 2016 · The International Journal of Biochemistry & Cell Biology
76. Differentiated super-enhancers in lung cancer cells
    Xin Li, Chengjun Lu, Qijue Lu, Chunguang Li, Ji Jun Zhu, Tiejun Zhao, Hezhong Chen, Hai Dan Jin · 2019 · Science China Life Sciences
77. Long-range chromatin interactions in pathogenic gene expression control
    Nahyun Kong, Inkyung Jung · 2020 · Transcription
78. Transcription Factors, R-Loops and Deubiquitinating Enzymes: Emerging Targets in Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Silvia M.L. Barabino, Elisabetta Citterio, Antonella Ellena Ronchi · 2021 · Cancers
79. NR4A3 fluorescence in situ hybridization analysis in cytologic and surgical specimens of acinic cell carcinoma
    Qiuying Shi, Bin Zhang, Caroline Bsirini, Liqiong Li, Ellen J. Giampoli, Kelly R. Magliocca, Michelle Dian Reid, Zhongren Zhou · 2022 · Human Pathology
80. The presence of additional cytogenetic aberrations in chronic myeloid leukemia cells at the time of diagnosis or their appearance on tyrosine kinase inhibitor therapy predicts the imatinib treatment failure
    Błażej Ratajczak, Anna Przybyłowicz-Chalecka, Joanna Czerwińska-Rybak, Zuzanna Kanduła, Adam Ustaszewski, Lidia Gil, Krzysztof Lewandowski, Małgorzata Jarmuż‐Szymczak · 2023 · Leukemia Research
81. Shaping the nebulous enhancer in the era of high-throughput assays and genome editing
    Edwin Yu-Kiu Ho, Qin Cao, Mengting Gu, Ricky Wai-Lun Chan, Qiong Wu, Mark Gerstein, Kevin Yuk-Lap Yip · 2019 · Briefings in Bioinformatics
82. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone
    Yvonne Lisa Behrens, Andrea Schienke, Claudia Davenport, Jana Lentes, Marcel Tauscher, Doris Steinemann, Mareike Rasche, Stephanie Knirsch, Stefanie Joachim, Dirk Reinhardt et al. · 2021 · Cancer Genetics
83. Current Cytogenetic Abnormalities in Acute Myeloid Leukemia
    Mounia Bendari, Nisrine Khoubila, Siham Cherkaoui, Nezha Hda, Meryem Qachouh, Mouna Lamchahab, Asmaa AQ Quessar · 2020 · IntechOpen eBooks
84. The genomic false shuffle: epigenetic maintenance of topological domains in the rearranged gibbon genome
    Nathan H. Lazar, Kimberly A. Nevonen, Brendan L. O’Connell, Richard Edward Green, Thomas Joshua Meyer, Mariam Okhovat, Lucia Carbone · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
85. Non-coding germline GATA3 variants alter chromatin topology and contribute to pathogenesis of acute lymphoblastic leukemia
    Hongbo Yang, Hui Zhang, Yu Luan, Tingting Liu, Kathryn G. Roberts, Maoxiang Qian, Bo Zhang, Wenjian Yang, Virginia Pérez-Andreu, Jie Xu et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
86. Cis -regulatory Element Hijacking by Structural Variants Overshadows Higher-Order Topological Changes in Prostate Cancer
    James R. Hawley, Stanley Zhou, Christopher Arlidge, Giacomo Grillo, Ken Kron, Rupert Hugh-White, Theodorus van der Kwast, Michael E. Fraser, Paul C. Boutros, Robert Glen Bristow et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
87. Redistribution of super-enhancers promotes malignancy in human hepatocellular carcinoma
    Jiacheng Huang, Liang Xu, Ye Chen, Mengqing Sun, Yiqing Hu, Caixu Pan, Liangyu Jiang, Menglan Wang, Jing Liu, Heng Dong et al. · 2025 · Journal of Advanced Research
88. Enhancer regulation in cancer: from epigenetics to m6A RNA modification
    Arathy Vasukutty, Poshan Yugal Bhattarai, Hong Seok Choi · 2025 · Archives of Pharmacal Research
89. Super-enhancers in immune system regulation: mechanisms, pathological reprogramming, and therapeutic opportunities
    Xin Lai, Caizhi Li, Xinglinzi Tang, Xinyi Luo, Feiyan Wu, Yuhong Liang, Bihui Huang, Hang Li · 2025 · Frontiers in Immunology
90. BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML
    Christine E. Birdwell, Warren C. Fiskus, Christopher Peter Mill, Tapan Mahendra Kadia, Naval Guastad Daver, Courtney Denton Dinardo, Koji Sasaki, John A. Davis, Kaberi Das, Hanxi Hou et al. · 2025 · Leukemia
91. Promoter‐centred chromatin interactions associated with EVI1 expression in EVI1+3q− myeloid leukaemia cells
    Han-Leng Ng, Mark E. Robinson, Philippa C. May, Andrew J. Innes, Christina Hiemeyer, Niklas Feldhahn · 2024 · British Journal of Haematology
92. TCF3::HLF orchestrates an enhancer-promoter network with activation of MEF2C to promote immature HSC gene expression in leukemia
    Valdemar Priebe, Bartimée Galvan, Aneta Drakul, Nicola Margelisch, Júlia Aguadé-Gorgorió, Kaivalya Walavalkar, Yun Huang, Hanna K. A. Mikkola, Beat C. Bornhauser, Raffaella Santoro et al. · 2026 · Science Advances
93. Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome
    Ilaria Iacobucci, Charles Grenfell Mullighan · 2021 · Current Opinion in Hematology
94. Dynamic regulation of GATA2 in fate determination in hematopoiesis: possible approach to hPSC-derived hematopoietic stem/progenitor cells
    Ya Zhou, Bin Mao, Yijin Chen, Yuan Xue, Bo Chen, Yonggang Zhang, Feng Ma · 2020 · Blood Science
95. SEPHguarding acute myeloid leukemia
    Malini Gupta, Britta Will · 2022 · Cell stem cell
96. Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
    Yang Shi, Meiqi Wang, Dan Liu, Saif Ullah, Xing Ma, Huiyu Yang, Bing-Rong Liu · 2022 · Frontiers in Oncology
97. Enhancer Clusters Drive Type I Interferon-Induced TRAIL Overexpression in Cancer, and Its Intracellular Protein Accumulation Fails to Induce Apoptosis
    Carolina Di Benedetto, Taimoor Khan, Santiago Serrano-Saenz, Anthony Rodriguez-Lemus, Chananat Klomsiri, Tim-Mathis Beutel, Alysia Thach, Henning Walczak, Paola A. Betancur · 2023 · Cancers
98. Identifying prognostic gene panels in acute myeloid leukemia
    Joaquín Sánchez‐García, Josefina Serrano, Esther Prados de la Torre, Juana Serrano‐López, Clara Aparicio Pérez, Eva Barragán, Pau Montesinos · 2023 · Expert Review of Hematology
99. Recent advances in chromosome capture techniques unraveling 3D genome architecture in germ cells, health, and disease
    Nuruliarizki Shinta Pandupuspitasari, Faheem Ahmed Khan, Chunjie Huang, Azhar Ali, Muhammad Rizwan Yousaf, Farwa Shakeel, Ezi Masdia Putri, Windu Negara, Anis Muktiani, Bambang Waluyo Hadi Eko Prasetiyono et al. · 2023 · Functional & Integrative Genomics
100. Enhancer in cancer pathogenesis and treatment
     Zhuo Sun, Jinbo Fan, Yixiong Dang, Yufeng Zhao · 2023 · Genetics and Molecular Biology